Emergency departments face increased boarding times and uncompensated care burdens, particularly for psychiatric patients.

Overall, the reviewers wrote, most IBD therapies “appear safe and effective when used in chronic kidney disease, including on ...

Oncology leaders warn that declining reimbursements and policy gaps threaten patient access and drive inequities in cancer ...

Leaders from the world of reimbursement explored the complex relationship between payers and providers in oncology, focusing ...

The top conference coverage published on AJMC.com in 2025 came from several conferences held throughout the year, with ...

On this episode of Managed Care Cast, we’re talking with the co-editors in chief of The American Journal of Managed Care® ( ...

This year’s most-read articles on CKD highlighted research and insights on drug approvals, guidelines, and value-based care.

Phase 1 data presented by Andrew Brenner, MD, PhD, showed RNL-186 improved survival, reduced symptoms, and demonstrated ...

Five of 6 baseline health-related social needs (HSRNs) were found to be associated with higher odds of an emergency department visit, leading researchers to encourage health care systems to ...

The top content from the World Conference on Lung Cancer (WCLC) 2025 highlighted panels and abstracts presented during the event, including updated MARIPOSA data, emerging data in EGFR -positive ...

The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...

The ustekinumab (Stelara; Janssen Biotech) biosimilar DMB-3115 (Imuldosa; Accord BioPharma) demonstrated clinical efficacy and safety comparable to the reference product through 52 weeks in a recent ...